Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Zagzag

Showing results (141-150 of 189) with videos related to

Pageof 19
Sort By:
Biomaterials|February 9, 2018
Hacking macrophage-associated immunosuppression for regulating glioblastoma angiogenesisXin Cui, Renee-Tyler Tan Morales, Weiyi Qian, et al.
European Journal of Radiology|February 10, 2009
Relative cerebral blood volume measurements of low-grade gliomas predict patient outcome in a multi-institution settingGisele B Caseiras, Sophie Chheang, James Babb, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2023
Evaluation of the SSTR2-targeted Radiopharmaceutical 177Lu-DOTATATE and SSTR2-specific 68Ga-DOTATATE PET as Imaging Biomarker in Patients with Intracranial MeningiomaSylvia C Kurz, Elcin Zan, Christine Cordova, et al.
Neuro-Oncology|November 9, 2013
Activation of mTORC1/mTORC2 signaling in pediatric low-grade glioma and pilocytic astrocytoma reveals mTOR as a therapeutic targetMarianne Hütt-Cabezas, Matthias A Karajannis, David Zagzag, et al.
Neoplasia (New York, N.Y.)|December 17, 2016
Patient-Specific Screening Using High-Grade Glioma Explants to Determine Potential Radiosensitization by a TGF-β Small Molecule InhibitorN Sumru Bayin, Lin Ma, Cheddhi Thomas, et al.
Oncotarget|October 30, 2016
Stimulation of the toll-like receptor 3 promotes metabolic reprogramming in head and neck carcinoma cellsMathieu Veyrat, Sylvère Durand, Marion Classe, et al.
Neuroradiology|May 29, 2019
MR imaging phenotype correlates with extent of genome-wide copy number abundance in IDH mutant gliomasChih-Chun Wu, Rajan Jain, Lucidio Neto, et al.
Pituitary|November 3, 2025
Somatostatin 5 receptor expression in prolactinomas: Is there a role for Pasireotide in the management of prolactinomas?Nidhi Agrawal, Sonal Mehta, Richard A Feelders, et al.
Neuro-Oncology|August 14, 2008
High-grade glioma before and after treatment with radiation and Avastin: initial observationsIngeborg Fischer, Clare H Cunliffe, Robert J Bollo, et al.
Journal of Neuro-Oncology|January 8, 2015
Prognostic marker analysis in pediatric intracranial ependymomasRoger E McLendon, Eric Lipp, Diane Satterfield, et al.
Pageof 19

Showing results (141-150 of 189) with videos related to

Sort By:
Pageof 19
Biomaterials|February 9, 2018
Hacking macrophage-associated immunosuppression for regulating glioblastoma angiogenesisXin Cui, Renee-Tyler Tan Morales, Weiyi Qian, et al.
European Journal of Radiology|February 10, 2009
Relative cerebral blood volume measurements of low-grade gliomas predict patient outcome in a multi-institution settingGisele B Caseiras, Sophie Chheang, James Babb, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2023
Evaluation of the SSTR2-targeted Radiopharmaceutical 177Lu-DOTATATE and SSTR2-specific 68Ga-DOTATATE PET as Imaging Biomarker in Patients with Intracranial MeningiomaSylvia C Kurz, Elcin Zan, Christine Cordova, et al.
Neuro-Oncology|November 9, 2013
Activation of mTORC1/mTORC2 signaling in pediatric low-grade glioma and pilocytic astrocytoma reveals mTOR as a therapeutic targetMarianne Hütt-Cabezas, Matthias A Karajannis, David Zagzag, et al.
Neoplasia (New York, N.Y.)|December 17, 2016
Patient-Specific Screening Using High-Grade Glioma Explants to Determine Potential Radiosensitization by a TGF-β Small Molecule InhibitorN Sumru Bayin, Lin Ma, Cheddhi Thomas, et al.
Oncotarget|October 30, 2016
Stimulation of the toll-like receptor 3 promotes metabolic reprogramming in head and neck carcinoma cellsMathieu Veyrat, Sylvère Durand, Marion Classe, et al.
Neuroradiology|May 29, 2019
MR imaging phenotype correlates with extent of genome-wide copy number abundance in IDH mutant gliomasChih-Chun Wu, Rajan Jain, Lucidio Neto, et al.
Pituitary|November 3, 2025
Somatostatin 5 receptor expression in prolactinomas: Is there a role for Pasireotide in the management of prolactinomas?Nidhi Agrawal, Sonal Mehta, Richard A Feelders, et al.
Neuro-Oncology|August 14, 2008
High-grade glioma before and after treatment with radiation and Avastin: initial observationsIngeborg Fischer, Clare H Cunliffe, Robert J Bollo, et al.
Journal of Neuro-Oncology|January 8, 2015
Prognostic marker analysis in pediatric intracranial ependymomasRoger E McLendon, Eric Lipp, Diane Satterfield, et al.
Pageof 19